chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: TTOX
Symptoms: Allergy to vaccine
Clinical narrative: Initial information received on 25-Feb-2019 regarding an unsolicited valid non-serious case received from a physician. This case involves patient (with unknown demographic) who experienced allergy to tetanus vaccine and toxoid, while received vaccine TETANUS TOXOID. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect TETANUS TOXOID (lot number and Expiry date unknown) via unknown route in unknown administration site. On an unknown date, the patient developed a non-serious allergy to tetanus vaccine and toxoid (allergy to vaccine) (Unknown latency) following the administration of TETANUS TOXOID. (Other relevant tests included no lab data.) Final diagnosis was allergy to tetanus vaccine and toxoid. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for allergy. List of documents held by sender: none.
Age: 56.0
Sex: M
Vaccine: FLU4
Symptoms: Haemorrhage, Peripheral swelling
Clinical narrative: Patient presented to the pharmacy stating that the day after his vaccination all the fingers on both of his hands began swelling. He was in a lot of pain. His fingers began bleeding and oozing during the course of the past month. Patient reports that symptoms have recently improved.
Age: 1.58
Sex: M
Vaccine: DTAPIPVHIB, MMR, PNC13, VARCEL
Symptoms: Injection site swelling, Injection site vesicles, Pyrexia, Vaccination site discomfort
Clinical narrative: Fever of 100.6, was given TYLENOL moments after vaccination. Vitamin C was also given moments after. Injection site (right thigh) started to swell 2 days after vaccines were administered. Today, 9 days later the injection has several blisters and swelling on right thigh only.  Patient is constantly trying to scratch vaccination site.
Age: 51.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Headache, Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Headache, chills, fever of 101.4, redness and swelling at injection site.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, FLU4, HIBV, PNC13, RV5
Symptoms: Abdominal pain, Enema administration, Intussusception, Restlessness, Ultrasound scan
Clinical narrative: Pt received vaccines 02/13/19. On 02/27/19 pt had episodes of abdominal cramps with inability to rest. Parents took to ER for evaluation. Diagnosed with Intussusception.
Age: 1.25
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Injection site rash, Pain
Clinical narrative: Patient has bumps/small lumps on both legs. They are light purple, but fades away sometimes. Does not increase in size. Patient complains in pain when touched.
Age: 66.0
Sex: F
Vaccine: FLU4, PNC13
Symptoms: Computerised tomogram normal, Cough, Fatigue, Gait disturbance, Hypoaesthesia
Clinical narrative: Weakness in her forearms since October 7 2018, numbness in her left hand, she likes it in time to the pneumonia and flu vaccines. No treatment plan initiated by provider at first mention during visit on 10/7/18. "Hand weakness. Current Assessment & Plan Unclear as to relation to PREVNAR 13, she will be evaluated by neurology. Should this proved to be an adverse reaction, will need to report. Pt then went to ED on 12/14/18 see below #1 myasthenic crisis. Patient decannulated on 1/12/2019 tolerated this well. Patient has road test today and was satting 96% on RA with ambulation. No need for home O2. CT scan in ICU showed no evidence of thymoma. She is has completed another 5 day course of IVIG whilst on the medicine floor. Continued management with the assistance of the neurology service. Continue on pyridostigmine as outpatient. Plan for outpatient repetitive nerve stimulation. Recommendations from Neurology are for follow up with Dr. for repeat IVIG in one month. Urgent referral has been placed. Saw Neurology on 1/17/19. Currently on mestinon 60 mg q 6 hours (waking up to take it even when asleep.) Was not placed on steroids by report. Since being at home started to have some excess salivation, coughing, dry heaves/nausea. Fortunately no falls. Ambulation seems more difficult due to her hip issues. No choking but cautious. Supposed to be scheduled for outpatient PT but she has been slightly more fatigue. Patient is now on O2 concentrator at home.
Age: 66.0
Sex: F
Vaccine: FLU4, PNC13
Symptoms: Immunoglobulin therapy, Intensive care, Laboratory test, Muscular weakness, Nausea
Clinical narrative: Weakness in her forearms since October 7 2018, numbness in her left hand, she likes it in time to the pneumonia and flu vaccines. No treatment plan initiated by provider at first mention during visit on 10/7/18. "Hand weakness. Current Assessment & Plan Unclear as to relation to PREVNAR 13, she will be evaluated by neurology. Should this proved to be an adverse reaction, will need to report. Pt then went to ED on 12/14/18 see below #1 myasthenic crisis. Patient decannulated on 1/12/2019 tolerated this well. Patient has road test today and was satting 96% on RA with ambulation. No need for home O2. CT scan in ICU showed no evidence of thymoma. She is has completed another 5 day course of IVIG whilst on the medicine floor. Continued management with the assistance of the neurology service. Continue on pyridostigmine as outpatient. Plan for outpatient repetitive nerve stimulation. Recommendations from Neurology are for follow up with Dr. for repeat IVIG in one month. Urgent referral has been placed. Saw Neurology on 1/17/19. Currently on mestinon 60 mg q 6 hours (waking up to take it even when asleep.) Was not placed on steroids by report. Since being at home started to have some excess salivation, coughing, dry heaves/nausea. Fortunately no falls. Ambulation seems more difficult due to her hip issues. No choking but cautious. Supposed to be scheduled for outpatient PT but she has been slightly more fatigue. Patient is now on O2 concentrator at home.
Age: 66.0
Sex: F
Vaccine: FLU4, PNC13
Symptoms: Retching, Salivary hypersecretion, Tracheostomy tube removal
Clinical narrative: Weakness in her forearms since October 7 2018, numbness in her left hand, she likes it in time to the pneumonia and flu vaccines. No treatment plan initiated by provider at first mention during visit on 10/7/18. "Hand weakness. Current Assessment & Plan Unclear as to relation to PREVNAR 13, she will be evaluated by neurology. Should this proved to be an adverse reaction, will need to report. Pt then went to ED on 12/14/18 see below #1 myasthenic crisis. Patient decannulated on 1/12/2019 tolerated this well. Patient has road test today and was satting 96% on RA with ambulation. No need for home O2. CT scan in ICU showed no evidence of thymoma. She is has completed another 5 day course of IVIG whilst on the medicine floor. Continued management with the assistance of the neurology service. Continue on pyridostigmine as outpatient. Plan for outpatient repetitive nerve stimulation. Recommendations from Neurology are for follow up with Dr. for repeat IVIG in one month. Urgent referral has been placed. Saw Neurology on 1/17/19. Currently on mestinon 60 mg q 6 hours (waking up to take it even when asleep.) Was not placed on steroids by report. Since being at home started to have some excess salivation, coughing, dry heaves/nausea. Fortunately no falls. Ambulation seems more difficult due to her hip issues. No choking but cautious. Supposed to be scheduled for outpatient PT but she has been slightly more fatigue. Patient is now on O2 concentrator at home.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Injection site reaction, Skin warm
Clinical narrative: Patient is experiencing injection site reaction. Area of redness started as a small area, and today the area is larger than patient's handsize. Patient reports no raised areas or itching. Patient reports the area is warm to touch.
Age: 10.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema
Clinical narrative: Patient presented to clinic two days after receiving influenze vaccination. Patient has a 9cm diameter erythema area around injection site to left arm.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Dizziness, Headache, Immediate post-injection reaction, Myalgia, Nausea
Clinical narrative: The patient experienced right-sided arm pain which progressed to bilateral arm pain the following day headache and nausea as well as muscle aches. He did not have fever. Immediately after the immunization he developed lightheadedness and a near syncopal episode occurred. He lied down and once feeling better was sent home.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Pain in extremity, Presyncope
Clinical narrative: The patient experienced right-sided arm pain which progressed to bilateral arm pain the following day headache and nausea as well as muscle aches. He did not have fever. Immediately after the immunization he developed lightheadedness and a near syncopal episode occurred. He lied down and once feeling better was sent home.
Age: 58.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Patient presented to clinic after work (around 3:45 pm) with noted erythema, swelling and heat to left upper arm and shoulder area. Patient reports that it is also painful to touch. Patient advised to try benadryl 50 mg along with ice for 15-20 minutes at a time and report back to this office for further observation in the next day or 2.
Age: 84.0
Sex: F
Vaccine: VARZOS
Symptoms: Back pain, Injection site pain, Injection site swelling, Myalgia
Clinical narrative: Severe pain started 2/10 and radiated slowly from the left shoulder across the back almost to R shoulder. The neck muscles were very painful. The only swelling was local at inj. site. The pain was severe. TYLENOL helped along with local heat. The pain increased daily from 2/10 until it stopped on 2/17. No fever or GI issues.
Age: 73.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injected limb mobility decreased, Pain in extremity, Peripheral swelling
Clinical narrative: Patient came to the pharmacy on the morning of 2/28/19 stating that starting the evening after her vaccination on 2/26/19, her left arm started hurting. The following day, she experienced more pain and limited mobility in that arm and the arm became red and swollen. She showed me the arm which did appear red and swollen, but not at the injection site, but lower and towards the inner arm. She stated that she had already made a doctor's appointment and would be going there, but wanted to let us know. I called the patient in the evening of 2/28/19 to check on her and how she had been treated by her physician. She stated that the physician gave her a steroid shot, a prescription for an antihistamine, and an antibiotic because he could not rule out infection.
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Erythema, Pain, Skin warm, Swelling
Clinical narrative: Redness, Swelling, Warm to touch, Painful.
Age: 20.0
Sex: M
Vaccine: ANTH, JEV1, SMALL
Symptoms: Allergy test negative, Rash papular, Rash pruritic
Clinical narrative: Patient presented to our clinic on 23 Jan 2019, symptoms of pruritic papular skin eruption located on bilateral hand, elbow, foot, lower back. Provider prescribed Hydrocortisone cream and diphenhydramine HCL 25mg. Resolved symptoms on 6 Feb 2019.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Fever of 101.6 for 12 hours, dizziness, and swelling of the site. Redness and swelling persisited for 6 days.
Age: 46.0
Sex: F
Vaccine: HEP
Symptoms: Blood culture, Chills, Differential white blood cell count, Full blood count, Headache
Clinical narrative: Patient had a fever the evening following administration to 103F and was sustained over 48hrs, chills, tachycardia (heart rate 144), headache, soreness over injection site, headache, and yellow-tinted vision.
Age: 46.0
Sex: F
Vaccine: HEP
Symptoms: Injection site pain, Pyrexia, Tachycardia, Xanthopsia
Clinical narrative: Patient had a fever the evening following administration to 103F and was sustained over 48hrs, chills, tachycardia (heart rate 144), headache, soreness over injection site, headache, and yellow-tinted vision.
Age: 1.83
Sex: M
Vaccine: DTP, HEP, HIBV, IPV, MMR, PPV
Symptoms: Fatigue, Pyrexia, Tongue blistering
Clinical narrative: Fever 102.1. Blisters on tongue. Exhausted.
Age: 12.0
Sex: F
Vaccine: FLU4, HPV9, MNQ, TDAP, FLU4, HPV9, MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Pain in extremity
Clinical narrative: Red and swollen where injection was given. Warm to the touch and painful when raising her arm. Ice and ibuprofen recommended every 6 hrs as needed.
Age: 12.0
Sex: F
Vaccine: FLU4, HPV9, MNQ, TDAP, FLU4, HPV9, MNQ, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Pain
Clinical narrative: Red and swollen where injection was given. Warm to the touch and painful when raising her arm. Ice and ibuprofen recommended every 6 hrs as needed.
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Cardiac fibrillation, Constipation, Decreased appetite, Disorientation
Clinical narrative: Loss of appetite for 5 days. Disorientation for 2 weeks, general malaise, sever constipation. Constant fatigue and lightheaded for 7 days, weak urination, heart fibrillations for 3 days, whole body weakness for 5 days, poor sleep for 7 days. Constant body sweats for 5 days. High temperature, profuse perspiration after a short walk. First week intense lightheaded almost led to passing out.
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Dizziness, Fatigue, Hyperhidrosis, Loss of consciousness, Malaise
Clinical narrative: Loss of appetite for 5 days. Disorientation for 2 weeks, general malaise, sever constipation. Constant fatigue and lightheaded for 7 days, weak urination, heart fibrillations for 3 days, whole body weakness for 5 days, poor sleep for 7 days. Constant body sweats for 5 days. High temperature, profuse perspiration after a short walk. First week intense lightheaded almost led to passing out.
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Micturition disorder, Poor quality sleep, Pyrexia
Clinical narrative: Loss of appetite for 5 days. Disorientation for 2 weeks, general malaise, sever constipation. Constant fatigue and lightheaded for 7 days, weak urination, heart fibrillations for 3 days, whole body weakness for 5 days, poor sleep for 7 days. Constant body sweats for 5 days. High temperature, profuse perspiration after a short walk. First week intense lightheaded almost led to passing out.
Age: 1.25
Sex: M
Vaccine: FLU4, HIBV, PNC13
Symptoms: Blood immunoglobulin E normal, Erythema of eyelid, Lacrimation increased, Lip swelling, Rash macular
Clinical narrative: Approximately 15 minutes after vaccines given the patient developed watering of right eye with mild swelling and redness of right eyelid as well as rhinorrhea from right nostril. His right upper lip also became mildly swollen. He had a few skin blotches near his right temple. He was given a dose of Benadryl and within 20 minutes his symptoms as described above resolved.
Age: 1.25
Sex: M
Vaccine: FLU4, HIBV, PNC13
Symptoms: Rhinorrhoea, Skin test negative, Swelling of eyelid
Clinical narrative: Approximately 15 minutes after vaccines given the patient developed watering of right eye with mild swelling and redness of right eyelid as well as rhinorrhea from right nostril. His right upper lip also became mildly swollen. He had a few skin blotches near his right temple. He was given a dose of Benadryl and within 20 minutes his symptoms as described above resolved.
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Redness, swelling, heat, tenderness, all from injection site down to elbow.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: The patient experienced redness, swelling, and erythema about one inch below injection site. Patient is self treating with TYLENOL and ice pack. Symptoms started the morning after she received her shot and were still present at day 3.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Influenza like illness, Injection site erythema, Pain in extremity, Swelling face
Clinical narrative: Patient stated she had flu-like symptoms and sore arm the day after the vaccine. Today, she complained of redness on and around injection site (not tender or warm to touch, no pain). She also stated that she had swelling around her sinus area (on both sides of her face but more pronounced on her right side of face). She mentioned that the swelling was worse this morning. It is still visible but decreasing. Her husband who is an MD told her it is not an allergic reaction and that she should still receive the second dose. Patient's mother and husband also came in for the same injection on the same day. Both only experienced a sore arm.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache
Clinical narrative: Severe headache. Wasn't sure if I was suffering a side effect or a cerebral aneurysm. Considered ER visit but reading more about vaccine reassured me it was more likely from the SHINGRIX than a bleed.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Electromyogram, Hypoaesthesia, Muscular weakness, Pain
Clinical narrative: Burning, pain, numbness, swelling. I still have some pain and forearm weakness in both arms.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity, Swelling
Clinical narrative: Burning, pain, numbness, swelling. I still have some pain and forearm weakness in both arms.
Age: 70.0
Sex: F
Vaccine: TTOX, VARZOS, VARZOS
Symptoms: Fatigue, Headache, Musculoskeletal stiffness, Myalgia, Neck pain
Clinical narrative: SEVERE PAIN AND STIFFNESS IN LEFT ARM TOO PAINFUL TO MOVE. HEADACHE, PAIN IN NECK & FATIGUE THAT LASTED FOR 4 DAYS. HAD TO TAKE PARACETAMOL REGULARLY TO RELIEVE PAIN. UPPER MUSCLE STILL VERY TENDER AFTER 1 WEEK.
Age: 70.0
Sex: F
Vaccine: TTOX, VARZOS, VARZOS
Symptoms: Pain in extremity
Clinical narrative: SEVERE PAIN AND STIFFNESS IN LEFT ARM TOO PAINFUL TO MOVE. HEADACHE, PAIN IN NECK & FATIGUE THAT LASTED FOR 4 DAYS. HAD TO TAKE PARACETAMOL REGULARLY TO RELIEVE PAIN. UPPER MUSCLE STILL VERY TENDER AFTER 1 WEEK.
Age: 70.0
Sex: F
Vaccine: TTOX, VARZOS, VARZOS
Symptoms: Hypoaesthesia, Insomnia, Neck pain, Pain, Pain in extremity
Clinical narrative: SEVERE PAIN AND STIFFNESS IN LEFT ARM TOO PAINFUL TO MOVE. HEADACHE, PAIN IN NECK & FATIGUE THAT LASTED FOR 4 DAYS. HAD TO TAKE PARACETAMOL REGULARLY TO RELIEVE PAIN. UPPER MUSCLE STILL VERY TENDER AFTER 1 WEEK.
Age: 70.0
Sex: F
Vaccine: TTOX, VARZOS, VARZOS
Symptoms: Paraesthesia, Swelling
Clinical narrative: SEVERE PAIN AND STIFFNESS IN LEFT ARM TOO PAINFUL TO MOVE. HEADACHE, PAIN IN NECK & FATIGUE THAT LASTED FOR 4 DAYS. HAD TO TAKE PARACETAMOL REGULARLY TO RELIEVE PAIN. UPPER MUSCLE STILL VERY TENDER AFTER 1 WEEK.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Feeling abnormal, Influenza like illness
Clinical narrative: Flu-like symptoms for 7-10 days with another 1-2 weeks not feeling back to normal; haven't decided if my body can go through the second shot as I am petite and weigh 95 lbs. Would like to know protocol for taking two shots when low in weight and if one is being recommended for people with adverse side effects like myself.
Age: 82.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Pruritus, Rash
Clinical narrative: The day after the vaccination I developed a rash on my neck, upper chest and shoulders. The rash disappeared in 2 days. Very itchy after rash disappeared.
Age: 87.0
Sex: M
Vaccine: FLU4
Symptoms: Cerebral atrophy, Computerised tomogram head normal, Dizziness, Electrocardiogram normal, Posture abnormal
Clinical narrative: 87 yo male with history of COPD, HTN, past MI and lung cancer. Shortly after administration of flu vaccine, patient was in waiting room awaiting doctor's visit and was noted to be drowsy. Pt reported feeling lightheaded, dizzy. Patient began to slide down in chair so was lowered to the floor with assistance of staff. Patient awakened on the floor and stated I do not know how I go to the floor. VS: 168/79 HT 82 O2 sat 97% 2 l/m NC applied, RR 16. Patient assisted to stretcher gently by 4 staff members/safely. Patient awake/hrr/spont resp continue. Patient transferred via EMS to local hospital for evaluation of syncopal event. Outside hospital records show CT Head was done with no acute findings, noted cerebral atrophy and evidence of chronic microvascular ischemic changes. EKG normal. Patient's symptoms quickly improved. Pt reported to ED physician that he has had similar episodes in the past. Upon review of his chart, he does have a history of syncopal episodes (not noted to be related to vaccine administration) and has been worked up for this. Of note, he received flu vaccine last season without any adverse effect.
Age: 87.0
Sex: M
Vaccine: FLU4
Symptoms: Somnolence, Syncope
Clinical narrative: 87 yo male with history of COPD, HTN, past MI and lung cancer. Shortly after administration of flu vaccine, patient was in waiting room awaiting doctor's visit and was noted to be drowsy. Pt reported feeling lightheaded, dizzy. Patient began to slide down in chair so was lowered to the floor with assistance of staff. Patient awakened on the floor and stated I do not know how I go to the floor. VS: 168/79 HT 82 O2 sat 97% 2 l/m NC applied, RR 16. Patient assisted to stretcher gently by 4 staff members/safely. Patient awake/hrr/spont resp continue. Patient transferred via EMS to local hospital for evaluation of syncopal event. Outside hospital records show CT Head was done with no acute findings, noted cerebral atrophy and evidence of chronic microvascular ischemic changes. EKG normal. Patient's symptoms quickly improved. Pt reported to ED physician that he has had similar episodes in the past. Upon review of his chart, he does have a history of syncopal episodes (not noted to be related to vaccine administration) and has been worked up for this. Of note, he received flu vaccine last season without any adverse effect.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Erythema, Feeling hot, Pruritus, Urticaria
Clinical narrative: After child got KINRIX and MMR-V 10-15 min's. started to C/O hands and feet feel hot/itchy and were bright red, followed by breaking out with hives on face and generalize on body (arms, torso, legs). Patient given BENADRYL with good effect. W/I 1 hour of taken BENADRYL.
Age: 1.08
Sex: M
Vaccine: FLUX
Symptoms: Aphasia
Clinical narrative: Dad reports that prior to receivig his last vaccine on 12/27/18, he can say single syllable words, like hi, bye, no, yes and mama, dada. He also said that child would pay attention when he asks him to focus on his finger. He said that after the shot on 12/27/18, which was flu shot #2, child would not say any words, he just jabbers and runs around; he still makes eye contact and plays with his parents and family. H/O autism - dad said questionable vaccine - related.
Age: 45.0
Sex: F
Vaccine: FLU4
Symptoms: Flushing, Nasal inflammation, Pruritus, Vaccination complication
Clinical narrative: Reaction to influenza vaccine; s/s: itching, flushing, nasal inflammation. Pt reports going to E.R to address s/s, shortly after as our office closed at 5pm.
Age: 83.0
Sex: F
Vaccine: PNC13
Symptoms: Fatigue, Pain, Peripheral swelling, Pyrexia
Clinical narrative: Severe local pain, swollen arm, fever and prostration approximately 1 week.
Age: 81.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Injection site pruritus, Injection site rash, Injection site swelling, Skin warm
Clinical narrative: Patient developed an itchy rash at injection site the day after injection. Red skin warm to touch that spread down her arm, to her elbow. Patient was treated with Prednisone 20 mg - take one table by mouth 2 times daily for 5 days. Rx prescribed and started on 02/27/19. Patient advised to use ice at swelling site in arm and to follow up if symptoms get worse or do not improve in 5 days.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Gait disturbance, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: Local Rx in L thigh. Warm, no erythema, slight swelling, all decreased from last night. Was limping - is no longer. Child playful and active.
Age: 10.0
Sex: M
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Developed hives on 02/27/2019.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site erythema, Injection site pain, Injection site reaction
Clinical narrative: Reaction left thigh approx. 4" area redness and pain around both injection sites.
Age: 65.0
Sex: M
Vaccine: FLUA3
Symptoms: Death, Myocardial infarction
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 724443), concerns a 65-year-old, elderly, male patient. This is a review of safety profile of aIIV3 vaccine by analyzing the reports of aIIV3 submitted from 01-Jul-2016 through 30-Jun-2018 to the vaccine adverse event reporting system (VAERS). The patient's medical history and current conditions were not reported. It was unknown whether the patient was taking any concomitant medications at the time of vaccination. On 09-Oct-2017, the patient was administered with Fluad (TIV) (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, MF59, dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179303 and expiry date: not reported) for an unknown indication. On 11-Oct-2017, 2 days after vaccination, the patient experienced myocardial infarction and passed away. The patient's lab tests were not reported. The cause of death was reported as myocardial infarction. It was unknown whether the autopsy was done. The reporter considered the event myocardial infarction as serious (fatal). Non-significant case correction received with IRD 30-Mar-2018: The sentence it was unknown whether the patient was taking in concomitant medications at the time of vaccination' was corrected to it was unknown whether the patient was taking any concomitant medications at the time of vaccination' in narrative. The sentence an elderly male patient with unknown concurrent illness and medications had died due to myocardial infarction, two after receiving Fluad TIV' was corrected to an elderly male patient with unknown concurrent illness and medications had died due to myocardial infarction, two days after receiving Fluad TIV' in case comment. No other changes were made in the narrative. Follow-up received from other health professional on 19-Feb-2019: Literature information and secondary reporters was added in the general tab. E2B Company Number (US-SEQIRUS-201801307) was added in the additional information tab.; Reporter's Comments: A 65-year-old male patient with unknown concurrent illness and medications had died due to myocardial infarction, two days after receiving Fluad TIV. Considering the progressive age of the patient, the known etiopathogenesis of the event myocardial infarction, minimal information regarding medical history and drug history, the causal role of suspect vaccine seems unlikely. Hence, causality was assessed as not related. Reported Cause(s) of Death: Myocardial infarction.
Sex: F
Vaccine: PNC, PPV
Symptoms: Pneumonia
Clinical narrative: pneumonia; This spontaneous report as received from a pharmacist via other company Pfizer (reference # 2018352350) refers to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On an unknown date the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) injection (dose, route, lot# and expiry date not reported). Other suspect therapies included pneumococcal 4 6b 9v 14 18c 19f 23f conj vaccine (crm197)(PREVNAR). On an unknown date, after both shots and after visiting foreign country, the patient experienced pneumonia. The outcome of pneumonia was unknown. The causality assessment was not provided.       Upon internal review pneumonia was considered to be medically significant.
Age: 16.0
Sex: M
Vaccine: HPVX, MENB, MNQ, HPVX, MENB, MNQ
Symptoms: Blood pressure decreased, Syncope, Tachycardia
Clinical narrative: This spontaneous report was received from a consumer and refers to a 16 year old male patient. The patient does not have any medical history. The patient had previously received MENACTRA when he was probably 11 years old. The patient does not have any family history. On 31-AUG-2018, the patient received first dose of human papillomavirus vaccine: either GARDASIL or GARDASIL 9 (dose unspecified) intramuscularly in the left deltoid from lot # R003557 and expiry date 20-NOV-2020  for prophylaxis. Other suspect therapies included TRUMENBA, dose 1 at a dose of 0.5 ml once, intramuscularly in the left deltoid from lot # T52805 and expiry date 31-AUG-2019 administered around 31-AUG-2018 09:30, and MENACTRA dose 2, intramuscularly in the right deltoid from lot # U6015AA, expiry date: 06-OCT-2019 administered on the same day for prophylaxis. On 31-AUG-2018, the patient fainted within first 2 minutes of receiving TRUMENBA. It was reported that the patient developed vasovagal syncope after vaccination with a blood pressure of 70/38 (units not specified) and tachycardia. The patient's oxygen (O2) saturation was normal. There was no emergency room visit, however the physician was called the patient's room. The outcome of syncope was reported as recovered on 31-AUG-2018. The outcome of blood pressure decreased and tachycardia was unknown. Causality assessment was not provided. Upon internal review, syncope was determined to be medically significant.
Age: 16.0
Sex: M
Vaccine: HPVX, MENB, MNQ, HPVX, MENB, MNQ
Symptoms: Hypotension, Syncope, Tachycardia
Clinical narrative: This spontaneous report was received from a consumer and refers to a 16 year old male patient. The patient does not have any medical history. The patient had previously received MENACTRA when he was probably 11 years old. The patient does not have any family history. On 31-AUG-2018, the patient received first dose of human papillomavirus vaccine: either GARDASIL or GARDASIL 9 (dose unspecified) intramuscularly in the left deltoid from lot # R003557 and expiry date 20-NOV-2020  for prophylaxis. Other suspect therapies included TRUMENBA, dose 1 at a dose of 0.5 ml once, intramuscularly in the left deltoid from lot # T52805 and expiry date 31-AUG-2019 administered around 31-AUG-2018 09:30, and MENACTRA dose 2, intramuscularly in the right deltoid from lot # U6015AA, expiry date: 06-OCT-2019 administered on the same day for prophylaxis. On 31-AUG-2018, the patient fainted within first 2 minutes of receiving TRUMENBA. It was reported that the patient developed vasovagal syncope after vaccination with a blood pressure of 70/38 (units not specified) and tachycardia. The patient's oxygen (O2) saturation was normal. There was no emergency room visit, however the physician was called the patient's room. The outcome of syncope was reported as recovered on 31-AUG-2018. The outcome of blood pressure decreased and tachycardia was unknown. Causality assessment was not provided. Upon internal review, syncope was determined to be medically significant.
Age: 69.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Blister, Influenza like illness, Injection site pain, Malaise, Musculoskeletal pain
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received SHINGRIX (batch number MX2LT, expiry date 29th May 2021) for prophylaxis. On 12th February 2019, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. In February 2019, less than a week after receiving SHINGRIX, the patient experienced injection site pain, sickness and blister. On an unknown date, the outcome of the injection site pain and blister were unknown and the outcome of the sickness was recovered/resolved. It was unknown if the reporter considered the injection site pain, sickness and blister to be related to SHINGRIX. Additional details were provided as follows: The patient received the 2nd dose of SHINGRIX in left arm and the patient was sick and bed-ridden for 4 or 5 days after receiving the vaccine. The patient also experienced soreness at the injection site and developed blisters on the opposite arm (right arm). The reporter did not had any additional details.
Age: 69.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pain in extremity
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received SHINGRIX (batch number MX2LT, expiry date 29th May 2021) for prophylaxis. On 12th February 2019, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. In February 2019, less than a week after receiving SHINGRIX, the patient experienced injection site pain, sickness and blister. On an unknown date, the outcome of the injection site pain and blister were unknown and the outcome of the sickness was recovered/resolved. It was unknown if the reporter considered the injection site pain, sickness and blister to be related to SHINGRIX. Additional details were provided as follows: The patient received the 2nd dose of SHINGRIX in left arm and the patient was sick and bed-ridden for 4 or 5 days after receiving the vaccine. The patient also experienced soreness at the injection site and developed blisters on the opposite arm (right arm). The reporter did not had any additional details.
Age: 69.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Bedridden, Blister, Injection site pain, Malaise
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received SHINGRIX (batch number MX2LT, expiry date 29th May 2021) for prophylaxis. On 12th February 2019, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. In February 2019, less than a week after receiving SHINGRIX, the patient experienced injection site pain, sickness and blister. On an unknown date, the outcome of the injection site pain and blister were unknown and the outcome of the sickness was recovered/resolved. It was unknown if the reporter considered the injection site pain, sickness and blister to be related to SHINGRIX. Additional details were provided as follows: The patient received the 2nd dose of SHINGRIX in left arm and the patient was sick and bed-ridden for 4 or 5 days after receiving the vaccine. The patient also experienced soreness at the injection site and developed blisters on the opposite arm (right arm). The reporter did not had any additional details.
Age: 66.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes virus infection, Rash
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of itchy rash in a 66-year-old female patient who received SHINGRIX (batch number 4ZF42, expiry date 18th April 2021) for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of rash pruritic (1st dose received on 7th December 2018, for tolerance see case US2019GSK037162). On 14th February 2019, the patient received the 2nd dose of SHINGRIX (intramuscular). On 16th February 2019, 2 days after receiving SHINGRIX, the patient experienced itchy rash. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the itchy rash was not recovered/not resolved. It was unknown if the reporter considered the itchy rash to be related to SHINGRIX. Additional details were provided as follows: The patient received a dose of SHINGRIX on an unknown arm. Approximately 2 hours later, the patient experienced several bumps on her back which were itchy after receiving a dose of SHINGRIX. The patient was seen by a physician, but the reporter did not know what discussion or diagnosis was made. The reporter consented to follow up.
Age: 66.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Rash, Rash pruritic, Vaccine positive rechallenge
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of itchy rash in a 66-year-old female patient who received SHINGRIX (batch number 4ZF42, expiry date 18th April 2021) for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of rash pruritic (1st dose received on 7th December 2018, for tolerance see case US2019GSK037162). On 14th February 2019, the patient received the 2nd dose of SHINGRIX (intramuscular). On 16th February 2019, 2 days after receiving SHINGRIX, the patient experienced itchy rash. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the itchy rash was not recovered/not resolved. It was unknown if the reporter considered the itchy rash to be related to SHINGRIX. Additional details were provided as follows: The patient received a dose of SHINGRIX on an unknown arm. Approximately 2 hours later, the patient experienced several bumps on her back which were itchy after receiving a dose of SHINGRIX. The patient was seen by a physician, but the reporter did not know what discussion or diagnosis was made. The reporter consented to follow up.
Age: 65.0
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Allergy test negative, Injection site papule, Injection site pruritus
Clinical narrative: This case was reported by a physician via call center representative and described the occurrence of injection site itching in a 65-year-old male patient who received FLUARIX QUADRIVALENT 2018-2019 season (batch number 4ZY53, expiry date 30th June 2019) for prophylaxis. On 23rd October 2018, the patient received FLUARIX QUADRIVALENT 2018-2019 season (intramuscular) .5 ml. On 23rd October 2018, less than a day after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patient experienced injection site itching. On an unknown date, the patient experienced pruritus. The patient was treated with steroids nos (Steroids) and antihistamine. On an unknown date, the outcome of the injection site itching and pruritus were unknown. It was unknown if the reporter considered the injection site itching and pruritus to be related to FLUARIX QUADRIVALENT 2018-2019 season. Additional details were provided as follows: This case was reported by physician for himself. The patient received FLUARIX QUADRIVALENT 2018-2019 season on left deltoid. On the day of vaccination, the patient experienced itching at the site of injection on the left arm. Till the time of reporting, less than a year after receiving FLUARIX QUADRIVALENT 2018-2019 season, the itching has spread to both side of the arms and to both side of the feet and legs. The patient had been taking steroid and antihistamine medication. When he stops taking the medication the itching comes back. The patient wanted to know what should he do. Physician was referred to medical information team. No further details were provided.
Age: 65.0
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Injection site pruritus, Pruritus
Clinical narrative: This case was reported by a physician via call center representative and described the occurrence of injection site itching in a 65-year-old male patient who received FLUARIX QUADRIVALENT 2018-2019 season (batch number 4ZY53, expiry date 30th June 2019) for prophylaxis. On 23rd October 2018, the patient received FLUARIX QUADRIVALENT 2018-2019 season (intramuscular) .5 ml. On 23rd October 2018, less than a day after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patient experienced injection site itching. On an unknown date, the patient experienced pruritus. The patient was treated with steroids nos (Steroids) and antihistamine. On an unknown date, the outcome of the injection site itching and pruritus were unknown. It was unknown if the reporter considered the injection site itching and pruritus to be related to FLUARIX QUADRIVALENT 2018-2019 season. Additional details were provided as follows: This case was reported by physician for himself. The patient received FLUARIX QUADRIVALENT 2018-2019 season on left deltoid. On the day of vaccination, the patient experienced itching at the site of injection on the left arm. Till the time of reporting, less than a year after receiving FLUARIX QUADRIVALENT 2018-2019 season, the itching has spread to both side of the arms and to both side of the feet and legs. The patient had been taking steroid and antihistamine medication. When he stops taking the medication the itching comes back. The patient wanted to know what should he do. Physician was referred to medical information team. No further details were provided.
Age: 81.0
Sex: M
Vaccine: PNC13, PNC13
Symptoms: Arthralgia, Blood test normal, Electrocardiogram, Gait disturbance, Myalgia
Clinical narrative: Extreme pain left thigh; could not work. Took ADVIL for pain for 10 days. Pain remained and eventually went to see doctor on February 5, 2019 (Dr). Doctor could not fine issue; remained on ADVIL and took penicillin for ten days if condition was infection based. On February 11, could not take pain any further. Went to Emergency room. Treated by MD on February 11. Quickly diagnosed with Polymyalgia Rheumatica. Immediately put on Prednisone which is controlling pain at this time.  Prednisone (2x 10mg daily) has been taken from February 11 to today's date. Currently has follow up appointments with doctors monthly.
Age: 81.0
Sex: M
Vaccine: PNC13, PNC13
Symptoms: Pain in extremity, Polymyalgia rheumatica
Clinical narrative: Extreme pain left thigh; could not work. Took ADVIL for pain for 10 days. Pain remained and eventually went to see doctor on February 5, 2019 (Dr). Doctor could not fine issue; remained on ADVIL and took penicillin for ten days if condition was infection based. On February 11, could not take pain any further. Went to Emergency room. Treated by MD on February 11. Quickly diagnosed with Polymyalgia Rheumatica. Immediately put on Prednisone which is controlling pain at this time.  Prednisone (2x 10mg daily) has been taken from February 11 to today's date. Currently has follow up appointments with doctors monthly.
Age: 81.0
Sex: M
Vaccine: PNC13, PNC13
Symptoms: Blood test, Echocardiogram, Impaired work ability, Pain in extremity, Polymyalgia rheumatica
Clinical narrative: Extreme pain left thigh; could not work. Took ADVIL for pain for 10 days. Pain remained and eventually went to see doctor on February 5, 2019 (Dr). Doctor could not fine issue; remained on ADVIL and took penicillin for ten days if condition was infection based. On February 11, could not take pain any further. Went to Emergency room. Treated by MD on February 11. Quickly diagnosed with Polymyalgia Rheumatica. Immediately put on Prednisone which is controlling pain at this time.  Prednisone (2x 10mg daily) has been taken from February 11 to today's date. Currently has follow up appointments with doctors monthly.
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Feeling abnormal, Headache, Influenza like illness, Pain, Pain in extremity
Clinical narrative: Severe congestion at night, aches, headache, mild fever, "flu-like symptoms" lasting roughly 1 day. Injection in afternoon, woke up miserable next morning, felt bad all day, mild arm pain the next day.
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Pyrexia, Respiratory tract congestion
Clinical narrative: Severe congestion at night, aches, headache, mild fever, "flu-like symptoms" lasting roughly 1 day. Injection in afternoon, woke up miserable next morning, felt bad all day, mild arm pain the next day.
Age: 65.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: 65 yrs old female. Patient was seen for Annual PE and received the PCV 13 vaccine on right deltoid on 02/20/2019. Patient c/o pain, swelling and redness on right deltoid area one day after vaccine was received, on 02/21/2019. Patient seen at the office 5 days later on 02/26/2019. At the exam, she presents on right deltoid area, erythema 12x19 cm and tender, warm, induration area of 4x6 cm, also right axillar lymphadenopathy. 2019-02-28 at 09:40 PM On f/u visit 02/28/2019, Patient feeling better, less pain, less swelling and less redness. She denies fever or chills. Patient currently taking BACTRIM DS 1 po bid and Cephalexin 500 mg 1 po QID. Right, arm, deltoid area with faded erythema 11 x 18 cm and less tender, induration decreased to 4 x 5 cm. Recommended to continue with present treatment and f/u visit scheduled on 03/08/2019.
Age: 65.0
Sex: F
Vaccine: PNC13
Symptoms: Lymphadenitis
Clinical narrative: 65 yrs old female. Patient was seen for Annual PE and received the PCV 13 vaccine on right deltoid on 02/20/2019. Patient c/o pain, swelling and redness on right deltoid area one day after vaccine was received, on 02/21/2019. Patient seen at the office 5 days later on 02/26/2019. At the exam, she presents on right deltoid area, erythema 12x19 cm and tender, warm, induration area of 4x6 cm, also right axillar lymphadenopathy. 2019-02-28 at 09:40 PM On f/u visit 02/28/2019, Patient feeling better, less pain, less swelling and less redness. She denies fever or chills. Patient currently taking BACTRIM DS 1 po bid and Cephalexin 500 mg 1 po QID. Right, arm, deltoid area with faded erythema 11 x 18 cm and less tender, induration decreased to 4 x 5 cm. Recommended to continue with present treatment and f/u visit scheduled on 03/08/2019.
Age: 0.33
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Anaphylactic reaction, Angioedema, Drooling, Oedema mucosal
Clinical narrative: Angioedema, drooling, mucosal swelling. Treated for anaphylaxis with improved exam.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Impaired work ability, Influenza like illness, Injection site erythema
Clinical narrative: Injection site: Red, Hot, swollen, painful. Flu like symptoms- full body ache, fever, chills, severe fatigue. Unable to perform daily activities 3 days. Missed work. Took TYLENOL 1 gm. Q 6 hrs. for 3 days.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site swelling, Injection site warmth, Loss of personal independence in daily activities, Pain
Clinical narrative: Injection site: Red, Hot, swollen, painful. Flu like symptoms- full body ache, fever, chills, severe fatigue. Unable to perform daily activities 3 days. Missed work. Took TYLENOL 1 gm. Q 6 hrs. for 3 days.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Injection site: Red, Hot, swollen, painful. Flu like symptoms- full body ache, fever, chills, severe fatigue. Unable to perform daily activities 3 days. Missed work. Took TYLENOL 1 gm. Q 6 hrs. for 3 days.
Sex: U
Vaccine: VARCEL
Symptoms: Expired product administered, No adverse event
Clinical narrative: Information has been received from a pharmacist referring to a patient of unknown age and unknown gender. Information of concurrent condition, medical history, and drug reactions/allergies was not provided. Concomitant medication included sterile diluent. On 06-FEB-2019, the patient was vaccinated with one dose of expired VARIVAX (injection, lot # M006157 with expiration date 05-FEB-2019, dose detail was not reported), subcutaneously for prophylaxis. The sterile diluent (lot #/ expiration date unknown) that was used to reconstitute the VARIVAX was not expired. No adverse effect reported.